Immunogenicity and safety of the quadrivalent human papillomavirus vaccine in HIV-1-infected women.
Kojic EM, Kang M, Cespedes MS, Umbleja T, Godfrey C, Allen RT, Firnhaber C, Grinsztejn B, Palefsky JM, Webster-Cyriaque JY, Saah A, Aberg JA, Cu-Uvin S.
Kojic EM, et al.
Clin Infect Dis. 2014 Jul 1;59(1):127-35. doi: 10.1093/cid/ciu238. Epub 2014 Apr 9.
Clin Infect Dis. 2014.
PMID: 24723284
Free PMC article.
Clinical Trial.